Sheng-Mai-Yin inhibits doxorubicin-induced ferroptosis and cardiotoxicity through regulation of Hmox1

Peina Meng,Zhaoyang Chen,Tianhui Sun,Lili Wu,Yifan Wang,Tianwei Guo,Jin Yang,Jiebin Zhu
DOI: https://doi.org/10.18632/aging.205062
2023-09-30
Aging
Abstract:Doxorubicin (DOX) is a potent chemotherapeutic drug used for treating various cancers. However, its clinical use is limited due to its severe cardiotoxicity, which often results in high mortality rates. Sheng-Mai-Yin (SMY), a Traditional Chinese medicine (TCM) prescription, has been reported to exert a cardioprotective effect in various cardiovascular diseases, including DOX-induced cardiotoxicity (DIC). This study aimed to provide novel insights into the underlying cardioprotective mechanism of...
cell biology,geriatrics & gerontology,gerontology
What problem does this paper attempt to address?